Targeted Cancer Therapy Market to Reach US$ 175.48 Billion by 2035 Driven by Precision Oncology Adoption, ADC Innovation, and Regulatory Productivity Says Ast…

The market holds massive commercial potential driven by superior clinical outcomes. With ADCs and radioligands leading ...
The American Journal of Managed Care

Gaps in Molecular Testing Rates, Targeted Treatment Persist in MDS, AML

Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...
Soap Central

Who is Dr. Mariano Barbacid? Spanish oncologist and his team achieve pancreatic cancer regression after targeted combination therapy

According to CNIO, among the various kinds of cancer, pancreatic cancer remains one of the deadliest and is a widely known ...
Cure Today

Dual-Targeting CAR T Therapy Shows Potential in Advanced Kidney Cancer

CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...